Pulmonary MRA is a promising technique for detection
of pulmonary embolism without ionizing radiation. Unfortunately, a subset of
patients fail breath-holding during conventional MRA (cMRA). Free-breathing ultra-short
echo time (UTE)-MRA could overcome this limitation but would require a blood
pool contrast agent due to longer scan times. Ferumoxytol (FE) can be used as
an off-label MR-contrast agent with a blood half-life of 10-14 hours. This study
compared gadobenate dimeglumine (GD)-enhanced-UTE-MRA to FE-cMRA and FE-UTE-MRA,
using GD-cMRA as reference standard. Results suggest that FE-UTE-MRA has
improved performance compared to GD-cMRA for depicting non-vascular structures while
offering excellent angiographic image quality.
This abstract and the presentation materials are available to members only; a login is required.